
Igor Cavalcanti, a rising middleweight prospect who won 14 of his first 15 professional fights—all but one inside the first round—has been hit with a temporary suspension by the Nevada State Athletic Commission after testing positive for an exogenous form of 19-Norandrosterone (nandrolone). The Brazilian fighter, who earned a UFC contract earlier this year by defeating Oscar Ravello in Dana White’s Contender Series (DWCS) Season 10, had previously disclosed his nandrolone use to the UFC as part of medical treatment for a right knee injury involving a medial meniscus tear and cartilage damage.
Cavalcanti’s suspension comes despite his transparency with the organization, with his manager stating he was unaware of the upcoming UFC bout when the treatment began during preparations for a European fight six months prior. Though the NSAC has not yet determined the length of the suspension or any potential fine, Cavalcanti’s UFC debut—and his future with the promotion—now hang in the balance after a career defined by explosive first-round finishes and a 9-0 start in pro MMA before his lone loss in DWCS Season 10.

MLB · 4h ago
NBA · 10h ago
NHL · 10h ago
Major League Soccer · 10h ago
NHL · 11h ago
NHL · 11h ago
MLB · 12h ago
NBA · 12h ago
See all videos